Cargando…
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion
BACKGROUND: Glioblastoma patients commonly develop resistance to temozolomide chemotherapy. Hypoxia, which supports chemotherapy resistance, favors the expansion of glioblastoma stem cells (GSC), contributing to tumor relapse. Because of a deregulated sphingolipid metabolism, glioblastoma tissues co...
Autores principales: | Sousa, Nadia, Geiß, Carsten, Bindila, Laura, Lieberwirth, Ingo, Kim, Ella, Régnier-Vigouroux, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433583/ https://www.ncbi.nlm.nih.gov/pubmed/37587449 http://dx.doi.org/10.1186/s12885-023-11271-w |
Ejemplares similares
-
Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines
por: Oancea-Castillo, Liliana R., et al.
Publicado: (2017) -
A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy
por: Noack, J, et al.
Publicado: (2014) -
Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate
por: Hawkins, Cyntanna C., et al.
Publicado: (2020) -
The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V
por: Sun, Xu, et al.
Publicado: (2022) -
The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth
por: Zhang, Yan, et al.
Publicado: (2022)